mhurhangee/ep-ind-claims huggingface dataset:
An electric motor comprising a stator and an armature received within the stator for rotational movement within the stator, the armature comprising: an armature shaft on which a commutator is mounted; a lamination stack also mounted on the armature shaft and having a plurality of radially extending teeth, said teeth forming a plurality of slots therebetween arranged circumferentially around a periphery of the lamination stack; an end insulator arranged at an end of the lamination stack, the end insulator having a base portion fitted around the armature shaft and plurality of insulating teeth (606, 608, 610, 612) corresponding to the radially extending teeth of the lamination stack, said teeth forming a plurality of slots therebetween; and a plurality of coils wound in said lamination stack slots and said end insulator slots; characterised in that at least one of said insulating teeth ( 608, 610, 612) has a greater thickness than at least another of said insulating teeth (606, 608, 610); wherein at least two of the insulating teeth arranged opposite one another have the same thickness as the base portion; wherein thicknesses of a subset of said insulating teeth (608, 610, 612) gradually increase around the end insulator; wherein the base layer includes a main portion arranged along a first plane and two stepped surfaces arranged opposite one another along a second plane parallel to the first plane, and at least two of the plurality of teeth extend from the stepped surfaces. an armature shaft on which a commutator is mounted; a lamination stack also mounted on the armature shaft and having a plurality of radially extending teeth, said teeth forming a plurality of slots therebetween arranged circumferentially around a periphery of the lamination stack; an end insulator arranged at an end of the lamination stack, the end insulator having a base portion fitted around the armature shaft and plurality of insulating teeth (606, 608, 610, 612) corresponding to the radially extending teeth of the lamination stack, said teeth forming a plurality of slots therebetween; and a plurality of coils wound in said lamination stack slots and said end insulator slots; characterised in that at least one of said insulating teeth ( 608, 610, 612) has a greater thickness than at least another of said insulating teeth (606, 608, 610); wherein at least two of the insulating teeth arranged opposite one another have the same thickness as the base portion; wherein thicknesses of a subset of said insulating teeth (608, 610, 612) gradually increase around the end insulator; wherein the base layer includes a main portion arranged along a first plane and two stepped surfaces arranged opposite one another along a second plane parallel to the first plane, and at least two of the plurality of teeth extend from the stepped surfaces.
An aqueous pharmaceutical composition for use as a paediatric medicament in the treatment or prevention of vitamin A deficiency or a vitamin A deficiency-associated disease, wherein the composition comprises: - retinol or a pharmaceutically acceptable ester thereof, - one or more polyethylene glycol esters of hydroxystearic acid, and - one or more pharmaceutically acceptable excipients; wherein the composition has a pH in the range of about 5.5 to about 7.5; wherein the retinol or the pharmaceutically acceptable ester thereof and the one or more polyethylene glycol esters of hydroxystearic acid are present as micelles having a volume mean particle diameter, as determined by laser diffraction, of about 100 nm or less; wherein the composition has an osmolality of about 100 to about 600 mOsm/kg; wherein the composition is a transparent aqueous pharmaceutical composition; wherein the term "about", when used in connection with a numerical value, refers to ±10% of the indicated numerical value, and wherein the term "about", when used in connection with the endpoints of a range, refers to the range from the lower endpoint -10% of its indicated numerical value to the upper endpoint +10% of its indicated numerical value. - retinol or a pharmaceutically acceptable ester thereof, - one or more polyethylene glycol esters of hydroxystearic acid, and - one or more pharmaceutically acceptable excipients; wherein the composition has a pH in the range of about 5.5 to about 7.5; wherein the retinol or the pharmaceutically acceptable ester thereof and the one or more polyethylene glycol esters of hydroxystearic acid are present as micelles having a volume mean particle diameter, as determined by laser diffraction, of about 100 nm or less; wherein the composition has an osmolality of about 100 to about 600 mOsm/kg; wherein the composition is a transparent aqueous pharmaceutical composition; wherein the term "about", when used in connection with a numerical value, refers to ±10% of the indicated numerical value, and wherein the term "about", when used in connection with the endpoints of a range, refers to the range from the lower endpoint -10% of its indicated numerical value to the upper endpoint +10% of its indicated numerical value.
A chimeric antigen receptor comprising: (a) an antigen binding fragment of an antibody that specifically binds to B7 homolog 6, (b) a transmembrane region, and (c) an intracellular T-cell receptor signaling domain. (a) an antigen binding fragment of an antibody that specifically binds to B7 homolog 6, (b) a transmembrane region, and (c) an intracellular T-cell receptor signaling domain.
A device for read-out of a photoplethysmography, PPG, signal, said device comprising: a photodiode, which is configured to detect a PPG signal as intensity of light based on interaction of an emitted light signal with a blood flow of a subject, the photodiode comprising a first and a second terminal (114; 116) on opposite sides of the photodiode; and a read-out circuitry (110; 210) for reading out the PPG signal detected by the photodiode, the read-out circuitry (110; 210) comprising an input stage and an output stage; wherein the input stage is connected to receive a first input signal from the first terminal of the photodiode, a second input signal from the second terminal of the photodiode, and a DC bias voltage, and wherein the input stage is configured for current sensing to provide a fully differential amplification of the first input signal and the second input signal to a first current signal and a second current signal, and wherein the output stage (134; 234) is configured to receive the first current signal and the second current signal, wherein the first current signal and the second current signal comprise an AC component and a DC component of the PPG signal, and wherein the output stage (134; 234) is configured to generate a differential output voltage through a gain component. a photodiode, which is configured to detect a PPG signal as intensity of light based on interaction of an emitted light signal with a blood flow of a subject, the photodiode comprising a first and a second terminal (114; 116) on opposite sides of the photodiode; and a read-out circuitry (110; 210) for reading out the PPG signal detected by the photodiode, the read-out circuitry (110; 210) comprising an input stage and an output stage; wherein the input stage is connected to receive a first input signal from the first terminal of the photodiode, a second input signal from the second terminal of the photodiode, and a DC bias voltage, and wherein the input stage is configured for current sensing to provide a fully differential amplification of the first input signal and the second input signal to a first current signal and a second current signal, and wherein the output stage (134; 234) is configured to receive the first current signal and the second current signal, wherein the first current signal and the second current signal comprise an AC component and a DC component of the PPG signal, and wherein the output stage (134; 234) is configured to generate a differential output voltage through a gain component.
A system for mounting a rollable screen, comprising: - a screen roll adapted to roll-up and unroll said screen through rotation about an axial direction, and comprising an end having a hollow tube; - a coupling piece comprising: ∘ a neck element, comprising a sleeve adapted to be positioned in axial direction inside said tube, wherein contact surfaces comprised in said sleeve contact said tube, and wherein recess surfaces comprised in said sleeve define axial channels between said neck element and said tube; ∘ a transitional element fixedly connected to said neck element, adapted to support said screen roll during said rolling-up or unrolling, - one or multiple anchoring elements, adapted to fasten said neck element detachably to said tube, characterized in that in an anchored state said anchoring elements are clamped inside said axial channels, with an even clamping along the axial direction. - a screen roll adapted to roll-up and unroll said screen through rotation about an axial direction, and comprising an end having a hollow tube; - a coupling piece comprising: ∘ a neck element, comprising a sleeve adapted to be positioned in axial direction inside said tube, wherein contact surfaces comprised in said sleeve contact said tube, and wherein recess surfaces comprised in said sleeve define axial channels between said neck element and said tube; ∘ a transitional element fixedly connected to said neck element, adapted to support said screen roll during said rolling-up or unrolling, ∘ a neck element, comprising a sleeve adapted to be positioned in axial direction inside said tube, wherein contact surfaces comprised in said sleeve contact said tube, and wherein recess surfaces comprised in said sleeve define axial channels between said neck element and said tube; ∘ a transitional element fixedly connected to said neck element, adapted to support said screen roll during said rolling-up or unrolling, - one or multiple anchoring elements, adapted to fasten said neck element detachably to said tube,
Cartridge for testing an in particular biological sample, the cartridge comprising a fluid system having a plurality of channels, and a pump apparatus for conveying the sample and/or a fluid, the pump apparatus comprising a pump chamber which is elastically deformable or compressible at least in part and/or in portions by means of contact elements sliding over the pump chamber in order to convey the sample and/or a fluid, wherein the pump chamber is provided with an intermediate layer and a sliding layer for the contact elements, characterised in that the intermediate layer is thicker and/or softer or more flexible than the sliding layer.
Compounds that can be used as primary explosive characterized in that, said compounds are; • 4-nitro-5(dinitromethyl)imidazole obtained by addition of hydroxyl amine hydrochloride to 4-nitro-1H-imidazole-5-carbonitrile, shown with formula I; or • 4-nitro-5(dinitromethyl)imidazole sodium salt, shown with formula II, obtained by addition of sodium chloride (NaCl) to 4-nitro-5(dinitromethyl)imidazole ligand, characterized with formula I; or • 4-nitro-5(dinitromethyl)imidazole ammonium salt, shown with formula III, obtained by addition of ammonium chloride (NH 4 Cl) to 4-nitro-5(dinitromethyl)imidazole ligand, characterized with formula I; which can be used as both the starting material for synthesis of many novel primary explosive compounds, and as primary explosive, that can be preferred in lieu of lead styphnate and/or lead azide particularly at the defense industry, that doesn't cause any environmental pollution, and that shall have no negative impact on the human health. • 4-nitro-5(dinitromethyl)imidazole obtained by addition of hydroxyl amine hydrochloride to 4-nitro-1H-imidazole-5-carbonitrile, shown with formula I; or • 4-nitro-5(dinitromethyl)imidazole sodium salt, shown with formula II, obtained by addition of sodium chloride (NaCl) to 4-nitro-5(dinitromethyl)imidazole ligand, characterized with formula I; or • 4-nitro-5(dinitromethyl)imidazole ammonium salt, shown with formula III, obtained by addition of ammonium chloride (NH 4 Cl) to 4-nitro-5(dinitromethyl)imidazole ligand, characterized with formula I; which can be used as both the starting material for synthesis of many novel primary explosive compounds, and as primary explosive, that can be preferred in lieu of lead styphnate and/or lead azide particularly at the defense industry, that doesn't cause any environmental pollution, and that shall have no negative impact on the human health.
A connector assembly comprising a first connector and a second connector, one end of which being coupled to the first connector, and another end of the second connector opposite to said one end being designed for receiving one or more wires from a wire harness, the other end being formed in a round shape, laterally symmetrically based on a center portion, characterized in that the other end comprises partitions partitioning multiple wire passages from each other, and each partition comprises at the other end of the second connector a guide groove for receiving a wire emerging from the corresponding wire passage.
A method for operating a security element for securely storing data and/or for identifying a subscriber in a mobile communication network, wherein the security element comprises a central processor unit and a memory unit with a nonvolatile, rewritable memory having a multiplicity of memory cells in which there is deposited existing program code for the operation of the security element and there is implemented "wear leveling" mechanism in such a fashion that for the equal distribution of the write accesses of the processor unit to the memory cells of the non-volatile memory, the processor unit can, in a given state, always access only on a part of the multiplicity of memory cells of the nonvolatile memory, wherein the method comprises the step of depositing new program code for the operation of the security element in the memory cells of the nonvolatile memory which the processor unit is not intended to access in a given state, due to the "wear leveling" mechanism.
A cosmetic, comprising: a composite powder having an average particle diameter of less than 1 μm and comprising: titanium oxide; and a surface treatment layer provided on a surface of the titanium oxide and comprising 4-tert-butyl-4-methoxydibenzoylmethane, a fatty acid, and aluminum hydroxide; and at least one selected from the group consisting of sorbitan sesquioleate and sorbitan sesquiisostearate. a composite powder having an average particle diameter of less than 1 μm and comprising: titanium oxide; and a surface treatment layer provided on a surface of the titanium oxide and comprising 4-tert-butyl-4-methoxydibenzoylmethane, a fatty acid, and aluminum hydroxide; and titanium oxide; and a surface treatment layer provided on a surface of the titanium oxide and comprising 4-tert-butyl-4-methoxydibenzoylmethane, a fatty acid, and aluminum hydroxide; and at least one selected from the group consisting of sorbitan sesquioleate and sorbitan sesquiisostearate.
A shirt comprising a heat retaining fabric and a heat dissipating fabric, wherein the heat retaining fabric (2, 9, 3a, 3b) is configured to be arranged in a portion of a front of the shirt that covers at least a part of the pectoralis major muscle, in an upper portion of a back of the shirt, and in portions of the shirt, each of which covers at least a part of the upper arm, when the shirt is worn, the heat dissipating fabric (8a, 8b, 5a, 5b) is configured to be arranged in portions of the back of the shirt and in portions of the shirt, each of which covers the axillary region, when the shirt is worn, wherein each of the portions of the back of the shirt extends from the shoulder, passes through the side of the dorsum, and covers at least a part of the infraspinatus muscle, when the shirt is worn, and is connected to a portion of the shirt which covers the axillary region, and the heat retaining fabric arranged in the upper portion of the back of the shirt is separated from the heat retaining fabric (3a, 3b) arranged in the portions of the shirt, each covering at least a part of the upper arm, by the heat dissipating fabric (8a, 8b, 5a, 5b) arranged in the portions of the back of the shirt and in the portions of the shirt which cover the axillary region; characterised in that the heat retaining fabric arranged in the portion of the front of the shirt, covering at least a part of the pectoralis major muscle, covers most of the pectoralis major muscle and is connected to the heat retaining fabric (3a, 3b) arranged in the portions of the shirt, each covering at least a part of the upper arm. wherein the heat retaining fabric (2, 9, 3a, 3b) is configured to be arranged in a portion of a front of the shirt that covers at least a part of the pectoralis major muscle, in an upper portion of a back of the shirt, and in portions of the shirt, each of which covers at least a part of the upper arm, when the shirt is worn, the heat dissipating fabric (8a, 8b, 5a, 5b) is configured to be arranged in portions of the back of the shirt and in portions of the shirt, each of which covers the axillary region, when the shirt is worn, wherein each of the portions of the back of the shirt extends from the shoulder, passes through the side of the dorsum, and covers at least a part of the infraspinatus muscle, when the shirt is worn, and is connected to a portion of the shirt which covers the axillary region, and the heat retaining fabric arranged in the upper portion of the back of the shirt is separated from the heat retaining fabric (3a, 3b) arranged in the portions of the shirt, each covering at least a part of the upper arm, by the heat dissipating fabric (8a, 8b, 5a, 5b) arranged in the portions of the back of the shirt and in the portions of the shirt which cover the axillary region; characterised in that the heat retaining fabric arranged in the portion of the front of the shirt, covering at least a part of the pectoralis major muscle, covers most of the pectoralis major muscle and is connected to the heat retaining fabric (3a, 3b) arranged in the portions of the shirt, each covering at least a part of the upper arm.
An aqueous, topical antifungal composition which comprises, based on the total weight of the composition, 45 to 50 weight percent water, 0.1 to 5 percent by weight antifungal agent selected from the group consisting of terbinafine, naftifine, butenafine, amorolfine and pharmaceutically acceptable salts thereof, 1 to 5 percent by weight lactate ester of a C 2 to C 16 saturated aliphatic alcohol, 0.5 to 5 percent by weight monoprotic organic acid having a pKa value in the range of 3.8 to 5, 40 to 45 percent by weight C 2 to C 8 saturated aliphatic alcohol, and 1 to 3 percent by weight cationic galactomannan gum.
Rotary encoder for measuring a state variable of a rotating object, having a code disk (2a, 3a), which is connected to the object and performs a tumbling movement, having at least one signal unit for detecting a rotation of the code disk (2a, 3a) and an axial movement of the code disk (2a, 3a), the signal unit being designed such that it receives first signals, representing the rotational movement of the code disk (2a, 3a), and second signals representing the axial movement of the code disk (2a, 3a), and comprising an evaluation unit for determining an angle of rotation from the first signals from the signal unit and for determining a rotational speed of the object or an acceleration acting on the object from the second signals from the signal unit.
A fire-extinguishing binary chemical condensation composition comprising an acid neutralizer/ gaseous phlegmatizer - propellant; a liquid alkaline phlegmatizer aqueous ammonia, wherein said alkaline phlegmatizer is a mixture of aqueous ammonia with the chemical formula NH 3 x nH 2 O, where n = 0.5 - 4 and a neutral inhibitor selected from a fluorinated film-forming foaming agent and/or a cesium salt solution in the following volumetric ratio: aqueous ammonia/neutral inhibitor: from 99: 1 to 80: 20 respectively; and the acid neutralizer/ gaseous phlegmatizer - propellant is a mixture of carbon dioxide and a pressure stabilizer selected from nitrogen and air, and antifreeze in the following volumetric ratio: carbon dioxide/pressure stabilizer/antifreeze: from 80:15:5 to 97:2:1 respectively, in the following composition component ratios (wt.%): alkaline phlegmatizer with neutral inhibitor: 30 - 60, acid neutralizer/ gaseous phlegmatizer - propellant: remaining alkaline phlegmatizer with neutral inhibitor: 30 - 60, acid neutralizer/ gaseous phlegmatizer - propellant: remaining
A method (200; 300), comprising: receiving (206; 306), at a user equipment, a message including a service rejection sent by a network; starting (208; 308), at the user equipment, in response to the received message including the service rejection, a timeout period; waiting, at the user equipment, to send an attach request to the network until at least one of a radio resource control connection release is received from the network or the timeout period expires; characterized by: sending, by the user equipment, subsequent to the waiting, the attach request via an existing radio resource control connection, when the timeout period expires and a radio resource control connection release for the existing radio resource control connection has not been received at the user equipment; and sending, by the user equipment, subsequent to the waiting, the attach request via another radio resource control connection, when a radio resource control connection release for the existing radio resource control connection is received at the user equipment and the timeout period has not expired. receiving (206; 306), at a user equipment, a message including a service rejection sent by a network; starting (208; 308), at the user equipment, in response to the received message including the service rejection, a timeout period; waiting, at the user equipment, to send an attach request to the network until at least one of a radio resource control connection release is received from the network or the timeout period expires; characterized by: sending, by the user equipment, subsequent to the waiting, the attach request via an existing radio resource control connection, when the timeout period expires and a radio resource control connection release for the existing radio resource control connection has not been received at the user equipment; and sending, by the user equipment, subsequent to the waiting, the attach request via another radio resource control connection, when a radio resource control connection release for the existing radio resource control connection is received at the user equipment and the timeout period has not expired. sending, by the user equipment, subsequent to the waiting, the attach request via an existing radio resource control connection, when the timeout period expires and a radio resource control connection release for the existing radio resource control connection has not been received at the user equipment; and sending, by the user equipment, subsequent to the waiting, the attach request via another radio resource control connection, when a radio resource control connection release for the existing radio resource control connection is received at the user equipment and the timeout period has not expired.